COP vs MRSN · P/E 19, rev $34.92B vs rev $40.5M
ConocoPhillips (COP) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Latest reported COP revenue for 2026-06-30 was $34.92B. Net income was $6.11B. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
COP currently screens at market cap $135.49B and trailing P/E 18.8. MRSN currently screens at market cap $145.4M.
Not investment advice. Open the COP and MRSN stock pages for the full models.
Not investment advice.